4.3 Article

Novel Method to Estimate the Phenotypic Variation Explained by Genome-Wide Association Studies Reveals Large Fraction of the Missing Heritability

Journal

GENETIC EPIDEMIOLOGY
Volume 35, Issue 5, Pages 341-349

Publisher

WILEY-BLACKWELL
DOI: 10.1002/gepi.20582

Keywords

genome-wide association study; explained variance; missing heritability; maximum likelihood method

Funding

  1. GlaxoSmithKline
  2. University of Lausanne (Switzerland)
  3. Giorgi-Cavaglieri Foundation
  4. European Framework Project 6 AnEuploidy and EuroDia
  5. Swiss National Foundation [310000-112552]
  6. Swiss National Science Foundation [33CSCO-122661, 3100AO-116323/1]

Ask authors/readers for more resources

Genome-wide association studies (GWAS) are conducted with the promise to discover novel genetic variants associated with diverse traits. For most traits, associated markers individually explain just a modest fraction of the phenotypic variation, but their number can well be in the hundreds. We developed a maximum likelihood method that allows us to infer the distribution of associated variants even when many of them were missed by chance. Compared to previous approaches, the novelty of our method is that it (a) does not require having an independent (unbiased) estimate of the effect sizes; (b) makes use of the complete distribution of P-values while allowing for the false discovery rate; (c) takes into account allelic heterogeneity and the SNP pruning strategy. We applied our method to the latest GWAS meta-analysis results of the GIANT consortium. It revealed that while the explained variance of genome-wide (GW) significant SNPs is around 1% for waist-hip ratio (WHR), the observed P-values provide evidence for the existence of variants explaining 10% (CI = [8.5-11.5%]) of the phenotypic variance in total. Similarly, the total explained variance likely to exist for height is estimated to be 29% (CI = [28-30%]), three times higher than what the observed GW significant SNPs give rise to. This methodology also enables us to predict the benefit of future GWA studies that aim to reveal more associated genetic markers via increased sample size. Genet. Epidemiol. 35: 341-349, 2011. (C) 2011 Wiley-Liss, Inc.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.3
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available